These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29743148)

  • 1. When should Surgery be used for Recurrent Ovarian Carcinoma?
    Bommert M; Harter P; Heitz F; du Bois A
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):493-497. PubMed ID: 29743148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study.
    Falcone F; Scambia G; Benedetti Panici P; Signorelli M; Cormio G; Giorda G; Bogliolo S; Marinaccio M; Ghezzi F; Rabaiotti E; Breda E; Casella G; Fanfani F; Di Donato V; Leone Roberti Maggiore U; Greggi S
    Gynecol Oncol; 2017 Oct; 147(1):66-72. PubMed ID: 28716306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement.
    Harrison R; Zighelboim I; Cloven NG; Marcus JZ; Coleman RL; Karam A
    Gynecol Oncol; 2021 Dec; 163(3):448-452. PubMed ID: 34686355
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases.
    Fan XM; Zhang J; Niu SH; Li KX; Song CZ
    Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.
    Eisenkop SM; Friedman RL; Wang HJ
    Cancer; 1995 Nov; 76(9):1606-14. PubMed ID: 8635065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer.
    Conte C; Marchetti C; Loverro M; Giudice MT; Rosati A; Gallotta V; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2023 Feb; 33(2):137-144. PubMed ID: 36639195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
    Harter P; Sehouli J; Vergote I; Ferron G; Reuss A; Meier W; Greggi S; Mosgaard BJ; Selle F; Guyon F; Pomel C; Lécuru F; Zang R; Avall-Lundqvist E; Kim JW; Ponce J; Raspagliesi F; Kristensen G; Classe JM; Hillemanns P; Jensen P; Hasenburg A; Ghaem-Maghami S; Mirza MR; Lund B; Reinthaller A; Santaballa A; Olaitan A; Hilpert F; du Bois A;
    N Engl J Med; 2021 Dec; 385(23):2123-2131. PubMed ID: 34874631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
    Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Shibata K; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2019 Jun; 29(5):910-915. PubMed ID: 30839284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score.
    da Costa AA; Valadares CV; Mantoan H; Saito A; Salvadori MM; Guimarães AP; Sanches SM; Achatz MI; Baiocchi G
    Int J Gynecol Cancer; 2016 Mar; 26(3):449-55. PubMed ID: 26825830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis.
    Gulia S; Kannan S; Ghosh J; Rath S; Maheshwari A; Gupta S
    Int J Gynecol Cancer; 2023 Sep; 33(9):1440-1447. PubMed ID: 37567595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer.
    van de Laar R; Massuger LF; Van Gorp T; IntHout J; Zusterzeel PL; Kruitwagen RF
    Gynecol Oncol; 2015 May; 137(2):210-5. PubMed ID: 25677063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete tumor resection and demonstration of detailed anatomy of the porta hepatis in a patient with recurrent epithelial ovarian cancer.
    Taskiran C; Vatansever D; Misirlioglu S; Giray B; Kumcular T; Arvas M; Erkan M
    Int J Gynecol Cancer; 2021 Jan; 31(1):148-149. PubMed ID: 33303569
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
    Pappa C; Galaal K; Smyth S; Bristow RE; Khashan AS; Alazzam M
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015297. PubMed ID: 38934360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Chen J; Tang MQ; Liu Q; Cai SM
    J Surg Oncol; 2000 Sep; 75(1):24-30. PubMed ID: 11025458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for secondary debulking in ovarian cancer? A review of the current literature.
    Krause D; Richardson DL
    Curr Opin Obstet Gynecol; 2023 Feb; 35(1):1-5. PubMed ID: 36239548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.
    Peng P; Zhu ZH; Zhong ZJ; Zheng K; Yang JX; Cao DY; Shen K
    Br J Radiol; 2015 Aug; 88(1052):20150109. PubMed ID: 25989698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.